BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao J, Karalis KP. Regulation of Nuclear Factor-κB by Corticotropin-Releasing Hormone in Mouse Thymocytes. Molecular Endocrinology 2002;16:2561-70. [DOI: 10.1210/me.2001-0334] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Lindström TM, Bennett PR. The role of nuclear factor kappa B in human labour. Reproduction 2005;130:569-81. [DOI: 10.1530/rep.1.00197] [Cited by in Crossref: 206] [Cited by in F6Publishing: 194] [Article Influence: 12.1] [Reference Citation Analysis]
2 Novembri R, De Clemente C, Funghi L, Torricelli M, Voltolini C, Challis JR, Petraglia F. Corticotropin releasing hormone and Urocortin 2 activate inflammatory pathways in cultured trophoblast cell lines. Eur J Obstet Gynecol Reprod Biol 2015;195:200-5. [PMID: 26588439 DOI: 10.1016/j.ejogrb.2015.10.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Anton PM, Gay J, Mykoniatis A, Pan A, O'Brien M, Brown D, Karalis K, Pothoulakis C. Corticotropin-releasing hormone (CRH) requirement in Clostridium difficile toxin A-mediated intestinal inflammation. Proc Natl Acad Sci U S A 2004;101:8503-8. [PMID: 15159534 DOI: 10.1073/pnas.0402693101] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 2.6] [Reference Citation Analysis]
4 Margolis KG, Gershon MD. Neuropeptides and inflammatory bowel disease. Curr Opin Gastroenterol. 2009;25:503-511. [PMID: 19816171 DOI: 10.1097/mog.0b013e328331b69e] [Cited by in Crossref: 68] [Cited by in F6Publishing: 45] [Article Influence: 5.7] [Reference Citation Analysis]
5 Yang Y, Hahm E, Kim Y, Kang J, Lee W, Han I, Myung P, Kang H, Park H, Cho D. Regulation of IL-18 expression by CRH in mouse microglial cells. Immunology Letters 2005;98:291-6. [DOI: 10.1016/j.imlet.2004.12.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
6 Kokkotou E, Torres D, Moss AC, O’brien M, Grigoriadis DE, Karalis K, Pothoulakis C. Corticotropin-Releasing Hormone Receptor 2-Deficient Mice Have Reduced Intestinal Inflammatory Responses. J Immunol 2006;177:3355-61. [DOI: 10.4049/jimmunol.177.5.3355] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 4.1] [Reference Citation Analysis]
7 Venihaki M, Zhao J, Karalis KP. Corticotropin-releasing hormone deficiency results in impaired splenocyte response to lipopolysaccharide. J Neuroimmunol 2003;141:3-9. [PMID: 12965248 DOI: 10.1016/s0165-5728(03)00183-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
8 Hillhouse EW, Grammatopoulos DK. The molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology. Endocr Rev. 2006;27:260-286. [PMID: 16484629 DOI: 10.1210/er.2005-0034] [Cited by in Crossref: 239] [Cited by in F6Publishing: 230] [Article Influence: 14.9] [Reference Citation Analysis]
9 Dubicke A, Akerud A, Sennstrom M, Hamad RR, Bystrom B, Malmstrom A, Ekman-Ordeberg G. Different secretion patterns of matrix metalloproteinases and IL-8 and effect of corticotropin-releasing hormone in preterm and term cervical fibroblasts. Mol Hum Reprod 2008;14:641-7. [PMID: 18922847 DOI: 10.1093/molehr/gan060] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
10 Song X, Chen Q, Wang J, Mao Q, Xia W, Xu L, Jiang F, Dong G. Clinical and prognostic implications of an immune-related risk model based on TP53 status in lung adenocarcinoma. J Cell Mol Med 2021. [PMID: 34877770 DOI: 10.1111/jcmm.17097] [Reference Citation Analysis]
11 Mastorakos G, Karoutsou EI, Mizamtsidi M. Corticotropin releasing hormone and the immune/inflammatory response. eur j endocrinol 2006;155:S77-84. [DOI: 10.1530/eje.1.02243] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
12 Kiapekou E, Zapanti E, Mastorakos G, Loutradis D. Update on the role of ovarian corticotropin-releasing hormone: Ovarian CRH. Annals of the New York Academy of Sciences 2010;1205:225-9. [DOI: 10.1111/j.1749-6632.2010.05685.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
13 Karalis KP, Venihaki M, Zhao J, van Vlerken LE, Chandras C. NF-kappaB participates in the corticotropin-releasing, hormone-induced regulation of the pituitary proopiomelanocortin gene. J Biol Chem 2004;279:10837-40. [PMID: 14711817 DOI: 10.1074/jbc.M313063200] [Cited by in Crossref: 39] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
14 Okada S, Yamaguchi-Shima N, Shimizu T, Arai J, Yorimitsu M, Yokotani K. Brain nuclear factor kappa B is involved in the corticotropin-releasing factor-induced central activation of sympatho-adrenomedullary outflow in rats. Eur J Pharmacol 2008;584:207-12. [PMID: 18304530 DOI: 10.1016/j.ejphar.2008.01.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
15 Smith EM, Gregg M, Hashemi F, Schott L, Hughes TK. Corticotropin Releasing Factor (CRF) activation of NF-kappaB-directed transcription in leukocytes. Cell Mol Neurobiol 2006;26:1021-36. [PMID: 16633893 DOI: 10.1007/s10571-006-9040-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
16 Gross KJ, Pothoulakis C. Role of neuropeptides in inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:918-932. [PMID: 17343284 DOI: 10.1002/ibd.20129] [Cited by in Crossref: 123] [Cited by in F6Publishing: 111] [Article Influence: 8.2] [Reference Citation Analysis]
17 Arzt E, Holsboer F. CRF signaling: molecular specificity for drug targeting in the CNS. Trends in Pharmacological Sciences 2006;27:531-8. [DOI: 10.1016/j.tips.2006.08.007] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 4.4] [Reference Citation Analysis]
18 Grammatopoulos DK. Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction. Br J Pharmacol 2012;166:85-97. [PMID: 21883143 DOI: 10.1111/j.1476-5381.2011.01631.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 7.5] [Reference Citation Analysis]
19 Vitoratos N, Mastorakos G, Kountouris A, Papadias K, Creatsas G. Positive association of serum interleukin-1β and CRH levels in women with pre-term labor. J Endocrinol Invest 2007;30:35-40. [DOI: 10.1007/bf03347393] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
20 Gay J, Kokkotou E, O'Brien M, Pothoulakis C, Karalis KP. Corticotropin-releasing hormone deficiency is associated with reduced local inflammation in a mouse model of experimental colitis. Endocrinology. 2008;149:3403-3409. [PMID: 18403481 DOI: 10.1210/en.2007-1703] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
21 Liu Y, Fang X, Yuan J, Sun Z, Li C, Li R, Li L, Zhu C, Wan R, Guo R, Jin L, Li S. The role of corticotropin-releasing hormone receptor 1 in the development of colitis-associated cancer in mouse model. Endocrine-Related Cancer 2014;21:639-51. [DOI: 10.1530/erc-14-0239] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
22 Moss AC, Anton P, Savidge T, Newman P, Cheifetz AS, Gay J, Paraschos S, Winter MW, Moyer MP, Karalis K. Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha. Gut. 2007;56:1210-1217. [PMID: 17412781 DOI: 10.1136/gut.2006.110668] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 3.5] [Reference Citation Analysis]
23 Slominski AT, Zmijewski MA, Zbytek B, Tobin DJ, Theoharides TC, Rivier J. Key role of CRF in the skin stress response system. Endocr Rev 2013;34:827-84. [PMID: 23939821 DOI: 10.1210/er.2012-1092] [Cited by in Crossref: 215] [Cited by in F6Publishing: 222] [Article Influence: 23.9] [Reference Citation Analysis]
24 Zbytek B, Pfeffer LM, Slominski AT. CRH inhibits NF-kappa B signaling in human melanocytes. Peptides 2006;27:3276-83. [PMID: 16959375 DOI: 10.1016/j.peptides.2006.07.017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
25 Gonçalves P, Magro F, Martel F. Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel. Inflamm Bowel Dis 2015;21:453-67. [PMID: 25248003 DOI: 10.1097/MIB.0000000000000209] [Cited by in Crossref: 43] [Cited by in F6Publishing: 18] [Article Influence: 6.1] [Reference Citation Analysis]
26 Benou C, Wang Y, Imitola J, VanVlerken L, Chandras C, Karalis KP, Khoury SJ. Corticotropin-releasing hormone contributes to the peripheral inflammatory response in experimental autoimmune encephalomyelitis. J Immunol 2005;174:5407-13. [PMID: 15843539 DOI: 10.4049/jimmunol.174.9.5407] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
27 Slominski A, Zbytek B, Zmijewski M, Slominski RM, Kauser S, Wortsman J, Tobin DJ. Corticotropin releasing hormone and the skin. Front Biosci 2006;11:2230-48. [PMID: 16720310 DOI: 10.2741/1966] [Cited by in Crossref: 112] [Cited by in F6Publishing: 104] [Article Influence: 7.0] [Reference Citation Analysis]
28 Smith EM. Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis. Brain Behav Immun 2008;22:3-14. [PMID: 17900859 DOI: 10.1016/j.bbi.2007.08.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
29 Cursano S, Battaglia CR, Urrutia-ruiz C, Grabrucker S, Schön M, Bockmann J, Braumüller S, Radermacher P, Roselli F, Huber-lang M, Boeckers TM. A CRHR1 antagonist prevents synaptic loss and memory deficits in a trauma-induced delirium-like syndrome. Mol Psychiatry. [DOI: 10.1038/s41380-020-0659-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
30 Kaprara A, Pazaitou-Panayiotou K, Kortsaris A, Chatzaki E. The corticotropin releasing factor system in cancer: expression and pathophysiological implications. Cell Mol Life Sci. 2010;67:1293-1306. [PMID: 20143250 DOI: 10.1007/s00018-010-0265-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
31 Chandras C, Koutmani Y, Kokkotou E, Pothoulakis C, Karalis KP. Activation of phosphatidylinositol 3-kinase/protein kinase B by corticotropin-releasing factor in human monocytes. Endocrinology 2009;150:4606-14. [PMID: 19628576 DOI: 10.1210/en.2008-1810] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]